Published on 8 Sep 2021 on Zacks via Yahoo Finance
It has been about a month since the last earnings report for Axsome Therapeutics (AXSM). Shares have added about 11.7% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Axsome due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Axsome's Q2 Earnings Beat Estimates, Revenues Nil